Preimplantation Genetic Testing Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Preimplantation Genetic Testing Market size is expected to grow at an annual average CAGR of 9% during 2022-2028. Preimplantation genetic diagnosis (PGD), also known as embryo screening, is a branch of genetics that involves genetic testing of embryos through in vitro fertilization (IVF). PGD ​​eliminates the risk of selective abortion in couples at significant risk of passing on serious genetic, chromosomal, or genetic disorders such as spinal muscular atrophy and cystic fibrosis.

The following segmentation are covered in this report:

By Test Type

• Chromosomal abnormalities
• Gender selection
• X-linked diseases
• Aneuploidy
• Single gene disorders
• Others

By Application

• Embryo HLA typing for stem cell therapy
• IVF Prognosis
• Late-Onset Genetic Disorders
• Inherited Genetic Disease
• Others

Company Profile

• Abbott Laboratories
• Agilent Technologies, Inc.
• BGI
• Fulgent Genetics, Inc.
• Igenomix
• Illumina, Inc.
• Invitae Corporation
• Myriad Genetics, Inc.
• MedGenome Labs Ltd.
• Natera, Inc.
• PerkinElmer, Inc.
• Pac Genomics
• Thermo Fisher Scientific Inc.

Scope of the report

The research study analyses the Preimplantation Genetic Testing Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Preimplantation Genetic Testing Market Report

• What was the Preimplantation Genetic Testing Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Preimplantation Genetic Testing Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.